The Medicines and Healthcare products Regulatory Agency (MHRA) today issued class 2 medicines recall for four batches of Sayana Press 104mg/0.65ml suspension for injection.
Pfizer, the sole supplier of the prescription-only medicine, is recalling the product from pharmacies, as an issue related to the sealing process for some units of Sayana Press for subcutaneous (SC) injection potentially impacting these batches.
Pharmacists are directed to quarantine all remaining stocks immediately and return it to suppliers using the approved process.
|Batch Number||Expiry Date||Pack Size||First Distributed|
|L61367||31 January 2020||1||10 April 2015|
|L61367Y||31 January 2020||1||02 May 2016|
|T34580||31 July 2020||1||08 November 2017|
|X49124||30 June 2021||1||09 October 2018|